$Reneo Pharmaceuticals (RPHM.US)$ NEWS Reneo Pharmaceuticals...
NEWS
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
Reneo Pharmaceuticals and OnKure announced a merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focusing on advancing OnKure's precision medicines in oncology. The combined company is expected to have $120 million in cash resources at close, funding through 2026. OnKure's lead program, OKI-219, is in a Phase 1 clinical trial for solid tumors.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
742Followers
76Following
4763Visitors
Follow
NoobGirl : do you think this is good news? not sure if Onkure pay any premium for the merger
Jaguar8OP NoobGirl: Have yet to read the details. Quite busy today and don’t deal on his since it’s a proposed merger
NoobGirl Jaguar8OP: they said is indefinite merger, and total value of both company will be 120m , Renoe 31% and Onkure 69%.
personally I don't know how to calculate but on face value seems like not a good deal 31% means around 36m, but today market cap already 50m+ so seems like is the value is diluted. I'm noob so I am not sure my understanding is correct
Jaguar8OP NoobGirl: I will not put much time with an indefinite merger. If they give certainty to it, then for me I’ll analyze it